HIGHLIGHTS
- who: Y. Gu from the Bristol Medical School, Translational Health Sciences, University of Bristol, Upper Maudlin Street, Bristol , HW, UK have published the research: Cell Therapy for Critical Limb Ischemia: Advantages, Limitations, and New Perspectives for Treatment of Patients with Critical Diabetic Vasculopathy, in the Journal: (JOURNAL)
- what: The review focuses on the perturbation of non-coding RNA networks in progenitor cells and the possibility of using emerging knowledge on molecular mechanisms to design refined protocols for personalized therapy. The authors provide some examples of studies using different cell types; second, the authors indicate how . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.